Top 10 Companies in the Guanidinium Thiocyanate (GTC) Market (2026): Market Leaders Driving Biotech Innovation

Global Guanidinium Thiocyanate (GTC) Market continues to expand as biomedicine and biotechnology demand high‑purity reagents for RNA and protein purification. The compound’s chaotropic properties make it indispensable for extracting intact nucleic acids and denaturing proteins, a requirement that grows alongside the rise of personalized medicine and biologics.

Guanidinium Thiocyanate (GTC) Market – View in Detailed Research Report

Market Size

The global Guanidinium Thiocyanate (GTC) market has been experiencing significant growth and is projected to continue its upward trajectory. In 2023, the market size for Guanidinium Thiocyanate (GTC) was estimated at USD 208 million. By 2032, this figure is expected to reach USD 363.53 million, exhibiting a compound annual growth rate (CAGR) of 6.40% during the forecast period.

North America is currently one of the dominant regions in the GTC market, with a projected market size of USD 60.31 million in 2023. The North American market is expected to grow at a CAGR of 5.49% from 2025 to 2032, driven by the increased use of GTC in biomedicine and chemical research. The rising demand for advanced protein and nucleic acid purification methods, particularly in the pharmaceutical and biotechnology sectors, plays a critical role in this expansion.

The historical trends of the GTC market show steady growth, driven by increasing research activities, innovations in biotechnology, and heightened demand for high‑quality biomolecule purification. Market drivers such as enhanced applications in RNA extraction, protein denaturation, and the inactivation of RNases contribute significantly to the demand for Guanidinium Thiocyanate. As biotechnology applications continue to expand, the future outlook for GTC remains promising, with considerable growth expected across various regions and applications.

Guanidinium Thiocyanate (GTC) is a powerful chaotropic agent, commonly used in laboratories and research institutions for protein and nucleic acid purification. As one of the most potent denaturants, GTC plays a crucial role in breaking down cellular structures, which facilitates the isolation of RNA, DNA, and proteins. It is particularly useful for RNA purification because it disrupts the cell’s integrity, allowing for easier extraction and separation of nucleic acids and proteins.

In addition to its use in RNA purification, GTC is employed in various biochemical and biotechnological processes, such as protein refolding and denaturation. Its ability to irreversibly inactivate nucleases makes it an essential reagent for applications where contamination by nucleases could lead to the degradation of critical biomolecules. The chaotropic properties of Guanidinium Thiocyanate are beneficial in nucleic acid extraction processes, such as the popular guanidinium thiocyanate‑phenol‑chloroform extraction method.

Market Dynamics

Drivers:

1. Increased Demand in Biomedicine and Biotechnology: The rise in biopharmaceuticals and biotechnology‑based research is a primary driver. The demand for high‑quality, uncontaminated RNA and protein samples has led to the growing adoption of Guanidinium Thiocyanate in research laboratories.

2. Rising Research and Development Activities: With the ongoing expansion of biotechnology, pharmaceutical, and healthcare industries, research activities have become more intensive. The demand for GTC is fueled by these industries’ need for better tools in molecular biology and genetic research.

3. Growth of Genetic Research: The growing interest in genomics, especially in personalized medicine, has fueled the need for highly effective nucleic acid extraction and purification methods, which GTC provides. As genetic research becomes a central focus in medical science, Guanidinium Thiocyanate’s importance continues to rise.

4. Advances in Protein Research: GTC’s ability to denature proteins and its role in protein refolding processes has led to its wide adoption in protein research and drug discovery. With the rise of biologics, the pharmaceutical industry’s reliance on GTC continues to grow.

5. Improved Access to Research Funding: Increased investments in scientific research, particularly in emerging markets, have accelerated the use of GTC in labs across the world. Many governments and organizations are investing heavily in genetic research, providing further demand for GTC.

Restraints:

1. Toxic and hazardous nature: GTC poses significant health and environmental risks, limiting its use in industries with strict safety standards.

2. Stringent regulatory frameworks: Compliance with environmental and chemical safety regulations—particularly in North America and Europe—raises operational costs.

3. Fluctuating raw material prices: Price volatility affects production planning and profit margins for manufacturers.

4. Logistics and transport issues: As a hazardous chemical, GTC faces restrictions in global shipping, complicating its distribution, especially to developing regions.

5. Emergence of safer alternatives: The availability of less hazardous and more user‑friendly compounds for similar applications may reduce GTC’s market share.

Top 10 Companies in the Guanidinium Thiocyanate (GTC) Market (2026)

1️⃣ 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: High‑purity GTC for RNA and protein purification

Merck’s GTC portfolio is engineered for laboratories that demand stringent purity levels, supporting a range of applications from academic research to pharmaceutical development. The company’s focus on quality control and scalable manufacturing ensures consistent supply to high‑volume users.

Sustainability Initiatives:

• Adoption of green chemistry protocols in GTC synthesis
• Commitment to reducing carbon footprint across production sites
• Investment in waste‑minimisation programs for hazardous chemicals

2️⃣ 2. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive GTC kits for nucleic acid extraction

Thermo Fisher supplies a full suite of GTC‑based reagents that integrate seamlessly with automated extraction platforms, catering to high‑throughput laboratories in genomics and diagnostics.

Sustainability Initiatives:

• Development of recyclable packaging for reagent vials
• Partnerships with research institutions to optimise reagent usage
• Transparency in chemical safety data sheets for end users

3️⃣ 3. ROTH GmbH

Headquarters: Rösrath, Germany
Key Offering: Ultra‑pure GTC for proteomics and structural biology

ROTH’s GTC is tailored for proteomic workflows, delivering low‑background contamination that preserves protein integrity during extraction and refolding.

Sustainability Initiatives:

• Use of renewable feedstocks in GTC production
• Implementation of closed‑loop water systems in manufacturing
• Continuous improvement of safety protocols for hazardous reagents

4️⃣ 4. Gold Biotechnology Ltd.

Headquarters: Shanghai, China
Key Offering: GTC formulations for high‑yield RNA extraction in clinical diagnostics

Gold Biotechnology focuses on delivering GTC solutions that support rapid turnaround in diagnostic laboratories, aligning with the demand for point‑of‑care testing.

Sustainability Initiatives:

• Investment in local manufacturing to reduce shipping emissions
• Compliance with China’s Chemical Safety Law
• Collaboration with universities to promote responsible reagent use

5️⃣ 5. Teknova Inc.

Headquarters: Melbourne, Australia
Key Offering: GTC reagents for next‑generation sequencing workflows

Teknova supplies GTC that is compatible with library preparation kits, ensuring high‑quality nucleic acid input for sequencing platforms.

Sustainability Initiatives:

• Adoption of ISO 14001 environmental management systems
• Optimization of energy use in production facilities
• Support for waste‑to‑energy conversion projects

6️⃣ 6. Promega Corporation

Headquarters: Madison, Wisconsin, USA
Key Offering: GTC‑based reagents for molecular biology and cell culture applications

Promega’s GTC products are designed to enhance reproducibility in molecular assays, offering robust performance across diverse experimental conditions.

Sustainability Initiatives:

• Launch of eco‑friendly packaging lines
• Reduction of hazardous waste through process optimisation
• Engagement with suppliers to ensure responsible sourcing

7️⃣ 7. ITW Incorporated

Headquarters: Champaign, Illinois, USA
Key Offering: GTC solutions for industrial‑scale biomolecule extraction

ITW targets large‑volume laboratories and biopharma manufacturers, providing GTC that meets stringent regulatory requirements for product safety.

Sustainability Initiatives:

• Implementation of energy‑efficient production lines
• Development of safer handling protocols for hazardous chemicals
• Collaboration with environmental agencies for compliance

8️⃣ 8. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High‑purity GTC for research and industrial applications

TCI supplies GTC that supports a broad spectrum of research fields, including microbiology, virology, and pharmaceutical development.

Sustainability Initiatives:

• Investment in renewable energy for manufacturing plants
• Adherence to Japan’s Chemical Substances Control Law
• Promotion of responsible chemical handling education

9️⃣ 9. Glentham Life Sciences Ltd.

Headquarters: Shanghai, China
Key Offering: GTC reagents for high‑throughput screening

Glentham focuses on delivering GTC that integrates with robotics and high‑content screening systems, enabling efficient sample preparation.

Sustainability Initiatives:

• Use of biodegradable packaging materials
• Optimization of raw‑material sourcing to reduce environmental impact
• Partnerships with academic labs for sustainable research practices

🔟 10. Polysciences, Inc. (Ott Scientific)

Headquarters: West Chester, Pennsylvania, USA
Key Offering: GTC products for diverse laboratory workflows

Polysciences supplies GTC that supports a range of applications from basic research to advanced diagnostics, ensuring consistent performance across laboratories.

Sustainability Initiatives:

• Development of low‑toxicity reagent formulations
• Implementation of waste‑reduction strategies in production
• Transparent safety data to aid user compliance

Download FREE Sample Report

Guanidinium Thiocyanate (GTC) Market – View in Detailed Research Report

Outlook: The Future of the GTC Market

The GTC market is set to expand as new therapeutic modalities and diagnostic platforms require reliable, high‑purity reagents. Growth in the Asia‑Pacific region, fueled by investments in research infrastructure, is expected to outpace traditional markets. Regulatory trends that favor safer chemical handling may accelerate the adoption of GTC in new applications.

Key Trends Shaping the Market

• Expansion of personalized medicine drives demand for precise nucleic‑acid purification.
• Emerging biopharma companies are adopting automated extraction systems that rely on GTC.
• Research into safer chaotropic agents may spur incremental shifts in usage patterns.
• Digital tracking of reagent usage enhances compliance and supply‑chain transparency.